41 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Katznelson, Endocrinologist in Los Angeles, CA?
What are Areas of Expertise for Dr. Katznelson?
Dr. Laurence Katznelson, MD is a highly-rated, board-certified Endocrinologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Katznelson empowers patients to confidently navigate their health journey, specializing in Acromegaly, Cushing's Syndrome, Neuroendocrine Tumors, Neuroendocrinology, Pituitary Disorders, and comprehensive wellness support. Serving the Los Angeles, CA community, Dr. Katznelson is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Katznelson go to medical school and complete their residency?
Fellowship: Massachusetts General Hospital
Residency: Hospital of the University of Pennsylvania | University of Pennsylvania Health System Program
Medical School: University of California
Is Dr. Katznelson board certified as an Endocrinologist?
Yes, Dr. Laurence Katznelson, MD is board certified by the American Board of Internal Medicine since 2013, American Board of Internal Medicine since 1988
What languages does Dr. Katznelson speak?
Dr. Katznelson and their clinical team can communicate with patients in the following languages:
- English
What conditions does an Endocrinologist like Dr. Katznelson typically treat?
As an Endocrinologist, Dr. Katznelson diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Katznelson. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Acromegaly
- Underactive Pituitary Gland
- Other Pituitary Gland Disorder
- Pituitary Disorder
- Sotos syndrome
- Combined pituitary hormone deficiency
- Isolated growth hormone deficiency
- Gigantism
- Growth Hormone Excess
- Pituitary Gigantism
- Hypopituitarism
- Pituitary Hormone Deficiency
- Low Pituitary Function
- Pituitary Gland Problems
- Hypothalamic-Pituitary Axis Dysfunction
- Endocrine Gland Disorders
ICD-10 Codes:
- E220: Acromegaly and pituitary gigantism
- E230: Hypopituitarism
- E236: Other disorders of pituitary gland
Also known as:
- Benign Pituitary Tumor
- Benign Tumor
- Pituitary Disorder
- Pituitary Tumor Treatment (PDQ)
- Prolactinoma
- Non-cancerous growth in pituitary gland
- Pituitary adenoma
ICD-10 Codes:
- D352: Benign neoplasm of pituitary gland
Also known as:
- Endocrine or Nervous System Tumor of Unspecified Behavior
- Endocrine Gland Neoplasm
- Nervous System Neoplasm
- Unspecified Gland Tumor
ICD-10 Codes:
- D497: Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system
Also known as:
- Testicular Hypofunction
- Testicular Disorder
- Underactive Testicles
- Low Testicular Function
- Hypogonadism
ICD-10 Codes:
- E291: Testicular hypofunction
What procedures does an Endocrinologist like Dr. Katznelson typically perform?
As an Endocrinologist, procedures performed by Dr. Laurence Katznelson may include:
- Adrenal Surgery
- Comparative Genomic Hybridization
- D and C / Vacuum Aspiration
- Diabetes Blood Sugar Management
- Diabetes Care - Kidney Disease Monitoring
- Diabetes Consultation
- Doppler Ultrasound
- Egg Freezing/ Fertility Preservation
Please contact Dr. Katznelson's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Katznelson accept my insurance?
Dr. Katznelson accepts most major insurance plans. Important: Please call our office at (310) 423-3870 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Katznelson accept in Los Angeles, CA?
Dr. Katznelson in Los Angeles, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Aetna
Blue Cross Blue Shield
Centene Corporation
Elevance Health Inc. (formerly Anthem)
Medicaid
Medicare
OptumRx Administered Payer
Other Provider Networks
Santa Cruz County
UnitedHealth Group
View All Insurances
Where is Dr. Katznelson's office located?
Dr. Laurence Katznelson's Primary Practice
8723 Alden Dr
Los Angeles, CA 90048
(310) 423-3870
What hospitals are Dr. Katznelson affiliated with?
Castle Connolly Top Hospital
This doctor is affiliated with a Castle Connolly Top Hospital.
Dr. Katznelson has admitting privileges at the following hospitals:
Recognitions
Publications
Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline
, 2011
Sustained Improvements in Plasma ACTH
, 2013
The dymics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing's
, 2011
Retrosellar intracranial extracerebral glioneurol heterotopion: case report
, 2010
Approach to the Patient with Persistent Acromegaly after Pituitary Surgery
, 2010
Non-surgical magement of hormone-secreting pituitary tumors
, 2009
Endogenous NIS Expression in Triple-Negative Breast Cancers
, 2009
Use of high-dose oral bisphosphote therapy for symptomatic fibrous dysplasia of the skull
, 2008
Late recurrences of Cushing's disease after initial successful transsphenoidal surgery
, 2008
Reninoma: case report and literature review
, 2008
Current thinking on the magement of the acromegalic patient.
, 2007
Pegvisomant for the treatment of acromegaly-translation of clinical trials into clinical practice
, 2007
Effects of modest testosterone supplementation and exercise
, 2006
Drug Insight: primary medical therapy of acromegaly
, 2006
Long-acting somatostatin alog therapy of acromegaly: A meta- alysis
, 2005
Diagnostic errors after inferior petrosal sinus sampling
, 2004
Effects of growth hormone secretion on body composition in patients with Crohn's disease
, 2003
Cardiovascular risk factors in acromegaly before
, 2002
Somatostatin receptor-specific alogs
, 2001
Hypogodism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study
, 2001
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
, 2000
Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas
, 1998
Global clinical response in Cushing's syndrome patients treated with mifepristone.
, 2014
Clinical characteristics
, 2013
Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline
, 2011
Fatigue after traumatic brain injury: Association with neuroendocrine, sleep
, 2010
Fatigue after TBI: Association with neuroendocrine abnormalities
, 2007
Clinical characteristics and pituitary dysfunction in patients with metastatic cancer to the sella.
, 2013
Sustained Improvements in Plasma ACTH
, 2013
In Reply: Pituitary Centers of Excellence.
Pituitary Centers of Excellence
, 2012
The dynamics of post
, 2011
American Association of Clinical Endocrinologists medical guidelines for clinical practice
, 2011
ECTOPIC ACROMEGALY DUE TO A PANCREATIC NEUROENDOCRINE TUMOR PRODUCING GROWTH HORMONE
, 2011
Retrosellar intracranial extracerebral glioneuronal heterotopion: case report
, 2010
Approach to the Patient with Persistent Acromegaly after Pituitary Surgery
, 2010
A NOVEL PRKAR1A MUTATION ASSOCIATED WITH PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE AND THE
, 2010
Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal
, 2009
Lanreotide promotes apoptosis and is not radioprotective in GH3 cells
, 2009
Non-surgical management of hormone-secreting pituitary tumors
, 2009
Alterations in body composition in acromegaly
, 2009
Endogenous NIS Expression in Triple-Negative Breast Cancers
, 2009
The impact of hypopituitarism on function
, 2009
Use of high-dose oral bisphosphonate therapy for symptomatic fibrous dysplasia of the skull
, 2008
An update on treatment strategies for acromegaly
, 2008
Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease
, 2008
Late recurrences of Cushing's disease after initial successful transsphenoidal surgery
, 2008
Reninoma: case report and literature review
, 2008
Current thinking on the management of the acromegalic patient.
, 2007
Pegvisomant for the treatment of acromegaly-translation of clinical trials into clinical practice
, 2007
Approach to the evaluation of the GH
, 2007
The role of inferior petrosal sinus sampling in the diagnostic localization of Cushing's disease.
, 2007
Brain atrophy and cognitive deficits in Cushing's disease.
, 2007
Efficacy and safety of CyberKnife radiosurgery for acromegaly.
, 2007
Effects of modest testosterone supplementation and exercise
, 2006
Isolated Langerhans cell histiocytosis in an adult with central diabetes insipidus
, 2006
Drug Insight: primary medical therapy of acromegaly
, 2006
Long-acting somatostatin analog therapy of acromegaly: A meta- analysis
, 2005
Diagnosis and treatment of acromegaly
, 2005
Diagnostic errors after inferior petrosal sinus sampling
, 2004
Effects of growth hormone secretion on body composition in patients with Crohn's disease
, 2003
Cardiovascular risk factors in acromegaly before
, 2002
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
, 2001
Somatostatin receptor-specific analogs
, 2001
Hypothalamic/pituitary function
, 2001
Hypogonadism in patients with acromegaly
, 2001
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
, 2000
Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas
, 1998
What is Dr. Katznelson's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Katznelson's National Provider Identifier (NPI) number is 1013082643.
What common questions do patients ask about Dr. Katznelson?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Katznelson